159 related articles for article (PubMed ID: 9374097)
1. Prospective assessment of cardiac toxicity during a randomized phase II trial of doxorubicin and paclitaxel in metastatic breast cancer.
Hortobagyi GN; Willey J; Rahman Z; Holmes FA; Theriault RL; Buzdar AU
Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-65-S17-68. PubMed ID: 9374097
[TBL] [Abstract][Full Text] [Related]
2. Treatment of metastatic breast cancer with paclitaxel and doxorubicin.
Dombernowsky P; Gehl J; Boesgaard M; Jensen TP; Jensen BW; Ejlertsen B
Semin Oncol; 1995 Dec; 22(6 Suppl 15):13-7. PubMed ID: 8643964
[TBL] [Abstract][Full Text] [Related]
3. Paclitaxel (Taxol)/doxorubicin combinations in advanced breast cancer: the Eastern Cooperative Oncology Group experience.
Sledge GW; Robert N; Sparano JA; Cobeligh M; Goldstein LJ; Neuberg D; Rowinsky E; Baughman C; McCaskill-Stevens W
Semin Oncol; 1994 Oct; 21(5 Suppl 8):15-8. PubMed ID: 7939756
[TBL] [Abstract][Full Text] [Related]
4. Combination chemotherapy with paclitaxel and doxorubicin for metastatic breast cancer.
Hortobagyi GN; Holmes FA; Theriault RL; Rahman Z; Buzdar AU
Semin Oncol; 1997 Aug; 24(4 Suppl 11):S11-13-S11-19. PubMed ID: 9314293
[TBL] [Abstract][Full Text] [Related]
5. Doxorubicin/paclitaxel combination chemotherapy for metastatic breast cancer: the Eastern Cooperative Oncology Group experience.
Sledge GW
Semin Oncol; 1995 Oct; 22(5 Suppl 12):123-5; discussion 126-9. PubMed ID: 7481854
[TBL] [Abstract][Full Text] [Related]
6. Paclitaxel and doxorubicin, a highly active combination in the treatment of metastatic breast cancer.
Dombernowsky P; Gehl J; Boesgaard M; Jensen TP; Jensen BV
Semin Oncol; 1996 Feb; 23(1 Suppl 1):13-8. PubMed ID: 8629030
[TBL] [Abstract][Full Text] [Related]
7. Paclitaxel in the treatment of metastatic breast cancer: M.D. Anderson Cancer Center experience.
Buzdar AU; Holmes FA; Hortobagyi GN
Semin Oncol; 1995 Jun; 22(3 Suppl 6):101-4. PubMed ID: 7541151
[TBL] [Abstract][Full Text] [Related]
8. Paclitaxel plus doxorubicin in metastatic breast cancer: preliminary analysis of cardiotoxicity.
Martin M; Lluch A; Ojeda B; Barnabas A; Colomer R; Massuti B; Benito D
Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-26-S17-30. PubMed ID: 9374088
[TBL] [Abstract][Full Text] [Related]
9. Doxorubicin and paclitaxel, a highly active combination in the treatment of metastatic breast cancer.
Dombernowsky P; Gehl J; Boesgaard M; Paaske T; Jensen BV
Semin Oncol; 1996 Oct; 23(5 Suppl 11):23-7. PubMed ID: 8893895
[TBL] [Abstract][Full Text] [Related]
10. Eastern Cooperative Oncology Group studies of paclitaxel and doxorubicin in advanced breast cancer.
Sledge GW; Robert N; Sparano JA; Cogleigh M; Goldstein LJ; Neuberg D; Rowinsky E; Baughman C; McCaskill-Stevens W
Semin Oncol; 1995 Jun; 22(3 Suppl 6):105-8. PubMed ID: 7597425
[TBL] [Abstract][Full Text] [Related]
11. Phase I/II study of dose-intense doxorubicin/paclitaxel/cyclophosphamide with peripheral blood progenitor cells and cytokine support in patients with metastatic breast cancer.
Rahman Z; Champlin R; Rondon G; Frye D; Valero V; Mehra R; Hortobagyi G
Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-77-S17-80. PubMed ID: 9374100
[TBL] [Abstract][Full Text] [Related]
12. Doxorubicin plus paclitaxel in advanced breast cancer.
Dombernowsky P; Boesgaard M; Andersen E; Jensen BV
Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-15-S17-8. PubMed ID: 9374086
[TBL] [Abstract][Full Text] [Related]
13. Paclitaxel and doxorubicin in metastatic breast cancer.
Gehl J; Boesgaard M; Paaske T; Jensen BV; Dombernowsky P
Semin Oncol; 1996 Dec; 23(6 Suppl 15):35-8. PubMed ID: 8996596
[TBL] [Abstract][Full Text] [Related]
14. Paclitaxel combination therapy in the treatment of metastatic breast cancer: a review.
Holmes FA
Semin Oncol; 1996 Oct; 23(5 Suppl 11):46-56. PubMed ID: 8893900
[TBL] [Abstract][Full Text] [Related]
15. Treatment of metastatic breast cancer with combination paclitaxel/cyclophosphamide.
Kennedy MJ; Donehower RC; Rowinsky EK
Semin Oncol; 1995 Aug; 22(4 Suppl 8):23-7. PubMed ID: 7543700
[TBL] [Abstract][Full Text] [Related]
16. Paclitaxel doublets in metastatic breast cancer: Eastern Cooperative Oncology Group and Hoosier Oncology Group Studies.
Sledge GW
Semin Oncol; 1996 Oct; 23(5 Suppl 11):57-9. PubMed ID: 8893901
[TBL] [Abstract][Full Text] [Related]
17. Paclitaxel with mitoxantrone with or without 5-fluorouracil and high-dose leucovorin in the treatment of metastatic breast cancer.
Greco FA; Hainsworth JD
Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-61-S17-64. PubMed ID: 9374096
[TBL] [Abstract][Full Text] [Related]
18. Experience at the Istituto Nazionale Tumori with paclitaxel in combination with doxorubicin in women with untreated breast cancer.
Gianni L; Capri G
Semin Oncol; 1997 Feb; 24(1 Suppl 3):S1-3. PubMed ID: 9071331
[TBL] [Abstract][Full Text] [Related]
19. Paclitaxel-containing combination chemotherapy for metastatic breast cancer.
Hortobagyi GN; Ibrahim N
Semin Oncol; 1996 Feb; 23(1 Suppl 1):53-7. PubMed ID: 8629039
[TBL] [Abstract][Full Text] [Related]
20. Combination paclitaxel (Taxol) and doxorubicin therapy for metastatic breast cancer.
O'Shaughnessy JA; Fisherman JS; Cowan KH
Semin Oncol; 1994 Oct; 21(5 Suppl 8):19-23. PubMed ID: 7939757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]